Financial Performance - The company reported a total revenue of RMB 1.2 billion for the first half of 2020, representing a year-on-year increase of 15%[13]. - The net profit attributable to shareholders was RMB 300 million, up 20% compared to the same period last year[13]. - The company's operating revenue for the first half of 2020 was CNY 1,906,696,858.19, representing a 33.30% increase compared to CNY 1,430,357,054.91 in the same period last year[20]. - The net profit attributable to shareholders for the first half of 2020 was CNY 252,145,035.28, a 25.63% increase from CNY 200,701,323.43 in the previous year[20]. - The net cash flow from operating activities increased by 79.32% to CNY 131,386,551.86, up from CNY 73,268,569.42 in the same period last year[20]. - The basic earnings per share for the first half of 2020 was CNY 1.40, an increase of 18.64% compared to CNY 1.18 in the same period last year[22]. - The company achieved a gross profit margin of approximately 32.9% for the first half of 2020, compared to 31.8% in the same period of 2019[148]. Business Expansion and Development - The company expanded its user base by 10% in the agricultural sector, reaching a total of 1.5 million active users[13]. - The company plans to launch three new pesticide products by the end of 2020, targeting a market share increase of 5%[13]. - The company is exploring potential acquisitions in the biotechnology sector to enhance its product portfolio[13]. - The company continues to focus on expanding its business layout in raw materials, formulations, and exports, enhancing its comprehensive competitiveness[31]. - The company has entered trial production for the Shandong Hailir thiamethoxam and thiamethoxam raw material projects in June 2020[27]. - The company has entered trial production for the second-generation neonicotinoid insecticides, Thiamethoxam and Thiamethoxam, as of June 2020[38]. - The company has expanded its overseas market presence, obtaining support registrations for over 900 products in 50 countries, including Australia and New Zealand[41]. Research and Development - Research and development expenses increased by 25% to RMB 150 million, focusing on innovative agricultural solutions[13]. - The increase in revenue is attributed to the strong performance of self-produced raw materials and formulations, as well as the acquisition of the thiamethoxam raw material business[22]. - The company has a strong R&D capability, recognized as a key high-tech enterprise under the National Torch Program, with a comprehensive pesticide R&D center[39]. - The company aims to enhance its comprehensive competitiveness by focusing on the three major business layouts of active ingredients, formulations, and exports[41]. Risk Management - The company has identified key risks including regulatory changes and market competition, with strategies in place to mitigate these risks[13]. - The company faces risks related to safety production and environmental protection due to the nature of its pesticide production, which involves flammable, explosive, and toxic materials[60]. - The company is committed to enhancing safety management and emergency response mechanisms to mitigate risks associated with production processes[61]. - Price fluctuations of raw pesticide products are influenced by market demand, upstream petrochemical prices, and environmental pressures, leading to production instability risks[62]. - The company is exposed to risks from upstream raw material supply and price volatility, which can impact production costs and profit margins[63]. Financial Position - The company's total assets at the end of the reporting period were CNY 3,928,159,427.27, a 12.33% increase from CNY 3,497,088,340.99 at the end of the previous year[20]. - The company’s net assets attributable to shareholders increased by 9.66% to CNY 2,459,731,954.30 from CNY 2,243,005,673.71 at the end of the previous year[20]. - The total liabilities as of June 30, 2020, were CNY 1,468,427,472.97, compared to CNY 1,254,082,667.28 at the end of 2019, reflecting an increase of around 17.1%[142]. - The total equity attributable to shareholders was CNY 2,459,731,954.30, compared to CNY 2,243,005,673.71 at the end of 2019, representing an increase of about 9.7%[142]. Shareholder and Governance - The actual controller and shareholders committed to not transferring or entrusting the management of shares for 36 months post-IPO, with a further two-year restriction on share reduction thereafter[74]. - The company appointed Zhongxinghua Accounting Firm as the auditor for the 2020 fiscal year, approved at the 2019 annual general meeting held on May 27, 2020[85]. - The company has a stock price stabilization plan in place to protect the interests of minority shareholders, which will be activated if the stock price falls below the net asset value per share within three years of its IPO[83]. - The company has not faced any penalties or corrective actions from regulatory bodies during the reporting period[85]. Environmental Management - The company’s subsidiary, Shandong Hailier, is classified as a key pollutant discharge unit and has implemented effective environmental management measures[94]. - The company emphasizes safety and environmental protection across its subsidiaries, ensuring all necessary discharge permits are in place[98]. - Shandong Hailier's environmental protection facilities include waste gas treatment systems such as RTO devices and bag dust collectors, with all facilities operating normally during the reporting period[101]. - Both companies have established emergency response plans for environmental incidents, with Shandong Hailier's plan being reviewed and filed in May 2020[103]. - The company has established an environmental self-monitoring plan in compliance with national regulations[113]. Accounting and Financial Reporting - The financial report was approved by the board of directors on August 27, 2020[170]. - The financial statements are prepared based on the assumption of going concern, indicating the company has the ability to continue operations for at least 12 months from the reporting date[173]. - The financial statements comply with the requirements of the accounting standards and reflect the company's financial position as of June 30, 2020, and the operating results for the first half of 2020[174]. - The company follows specific accounting treatments for business combinations, distinguishing between those under common control and those not under common control[178][180].

Financial Performance - Operating revenue for the period reached CNY 791,825,545.53, a 31.61% increase year-on-year[7] - Net profit attributable to shareholders was CNY 83,660,911.59, reflecting a 22.27% growth compared to the same period last year[7] - Basic earnings per share rose by 21.95% to CNY 0.50 per share[7] - Revenue for Q1 2020 reached CNY 791.83 million, an increase of 31.61% compared to CNY 601.66 million in Q1 2019[15] - Net profit for Q1 2020 was CNY 83.66 million, reflecting a growth of 22.27% from CNY 68.42 million in the same period last year[15] - Total operating revenue for Q1 2020 reached ¥791,825,545.53, a 31.6% increase from ¥601,662,147.59 in Q1 2019[29] - Net profit for Q1 2020 was ¥83,660,911.59, representing a 22.3% increase compared to ¥68,421,552.07 in Q1 2019[30] - The total profit for Q1 2020 was CNY 16.76 million, compared to CNY 3.66 million in Q1 2019, indicating a growth of 357.5%[33] Assets and Liabilities - Total assets increased by 9.66% to CNY 3,834,952,342.45 compared to the end of the previous year[7] - Cash and cash equivalents increased by 35.50% to CNY 541,119,491.11 due to the purchase of structured deposits[14] - Accounts receivable surged by 77.67% to CNY 676,593,354.98, attributed to increased shipments after the Spring Festival[14] - Total assets as of March 31, 2020, amounted to CNY 3.83 billion, up from CNY 3.50 billion at the end of 2019[21] - Total liabilities for Q1 2020 were ¥1,385,757,064.69, compared to ¥1,372,134,793.00 in Q1 2019[26] - Total current assets amounted to 2,096,877,301.58 RMB, with total assets at 3,497,088,340.99 RMB as of Q1 2020[43] - Current liabilities were approximately 1.37 billion, with accounts payable at 925.65 million and short-term borrowings at 82.30 million[48] - Total liabilities stood at approximately 1.37 billion, indicating a balanced financial structure[49] Cash Flow - The net cash flow from operating activities was negative at CNY -50,932,664.94, an improvement from CNY -61,904,237.26 in the previous year[7] - Cash flow from operating activities showed a net outflow of CNY 50.93 million in Q1 2020, an improvement from a net outflow of CNY 61.90 million in Q1 2019[36] - Cash flow from investing activities generated a net inflow of CNY 14.50 million in Q1 2020, compared to a net outflow of CNY 22.32 million in Q1 2019[37] - Cash inflow from financing activities totaled 249,676,897.20 RMB, while cash outflow was 191,604,352.58 RMB, resulting in a net cash flow of 58,072,544.62 RMB, down from 218,497,335.11 RMB in Q1 2019[40] Shareholder Information - The company had a total of 11,612 shareholders at the end of the reporting period[11] - The top shareholder, Zhang Aiying, holds 38.27% of the shares, totaling 64,925,000 shares[11] Research and Development - Research and development expenses increased by 68.84% to CNY 34.42 million, indicating a continued commitment to innovation[15] - Research and development expenses for Q1 2020 were ¥34,417,382.42, an increase from ¥20,385,158.61 in Q1 2019[30] - Research and development expenses increased to CNY 12.33 million in Q1 2020, up from CNY 9.97 million in Q1 2019, reflecting a growth of 23.5%[32] Financial Adjustments and Standards - The company adopted new revenue recognition standards starting January 1, 2020, which may impact future financial reporting[50] - The company reported a significant adjustment in pre-revenue recognition data due to the new accounting standards, affecting comparability with prior periods[50]

Dividend Policy - The company plans to distribute a cash dividend of 3 RMB per 10 shares (including tax) to all shareholders, and will also increase capital by 4 shares for every 10 shares held, subject to shareholder approval[5] - The company has a cash dividend policy that mandates a minimum of 10% of distributable profits to be distributed as cash dividends, provided certain conditions are met[157] - In 2019, the company distributed a cash dividend of 3 RMB per 10 shares and increased capital reserves by 4 shares per 10 shares[162] - The company’s cash dividends for 2019 amounted to approximately 50.89 million RMB, representing 16.11% of the net profit attributable to ordinary shareholders[162] - The company’s cash dividend distribution for 2018 was also 3 RMB per 10 shares, with a total of approximately 50.82 million RMB distributed[162] - The company’s cash dividend distribution for 2017 was 3 RMB per 10 shares, along with a capital reserve increase of 4 shares per 10 shares, totaling approximately 36 million RMB[162] Financial Performance - The company’s operating revenue for 2019 was CNY 2,466,784,002.17, representing a year-on-year increase of 12.56% compared to CNY 2,191,465,177.73 in 2018[21] - The net profit attributable to shareholders decreased by 14.05% to CNY 315,784,848.62 in 2019 from CNY 367,401,372.13 in 2018[21] - The net cash flow from operating activities significantly increased by 140.10% to CNY 586,577,102.59 in 2019, compared to CNY 244,307,282.99 in 2018[21] - The total assets at the end of 2019 were CNY 3,497,088,340.99, an increase of 8.28% from CNY 3,229,574,444.83 at the end of 2018[21] - The basic earnings per share for 2019 was CNY 1.88, down 14.16% from CNY 2.19 in 2018[22] - The weighted average return on equity decreased by 5.48 percentage points to 15.16% in 2019 from 20.64% in 2018[22] - The company reported a significant increase in cash flow due to adjustments in operational strategies, including reducing advance payments and increasing accounts payable[23] - The net assets attributable to shareholders increased by 14.64% to CNY 2,243,005,673.71 at the end of 2019 from CNY 1,956,564,549.58 at the end of 2018[21] - The company experienced a decline in net profit primarily due to falling raw material prices impacting profitability levels[23] - The company reported non-recurring gains of CNY 18,377,179.04 in 2019, compared to CNY 4,834,515.63 in 2018[28] Risk Management - The company reported no significant risks that could materially affect its operations during the reporting period[8] - The company has a comprehensive risk management strategy in place to address potential operational risks[8] - The company emphasizes the importance of understanding the risks associated with forward-looking statements regarding future development plans and strategies[6] - The company has not experienced any non-operational fund occupation by controlling shareholders or related parties[7] - The company acknowledges risks related to safety production and environmental protection, implementing comprehensive management and preventive measures[145][146] - The company faces price volatility risks in raw materials and production instability, responding with increased R&D investment and cost control measures[147][148] - The company is actively monitoring changes in agricultural and chemical industry regulations to mitigate risks associated with compliance[154] - The company is exposed to foreign exchange risks due to increasing export ratios, with a focus on mitigating these through hedging strategies[155] Business Operations - The company primarily engages in the research, production, and sales of pesticide formulations, intermediates, active ingredients, and water-soluble fertilizers, with no significant changes in its main business operations[32] - The company has established a centralized procurement model for bulk raw materials, signing large contracts with suppliers to secure annual procurement intentions and mitigate risks associated with price fluctuations[33] - The company has developed a diverse product range, holding 218 pesticide registration certificates, with a focus on integrating formulations, active ingredients, and intermediates to enhance overall competitiveness[43] - The company has a strong research and development capability, recognized as a key high-tech enterprise and has established a comprehensive pesticide R&D center covering all aspects of pesticide development[42] - The company has expanded its overseas market presence, obtaining support registrations for over 900 products in 50 countries, including Australia and New Zealand, and is actively pursuing registrations in additional countries[44] - The company aims to achieve a business layout focusing on active ingredients, formulations, and exports, while continuously enhancing its product dimensions and business channels[44] - The company has reported a significant increase in the market scale of its main active ingredients, with global production capacity for imidacloprid around 30,000 tons, predominantly located in China[35] - The company has acquired Kaiyuanxiang, adding the active ingredient Mavridine to its product portfolio, further strengthening its integrated advantages[41] - The company emphasizes product quality and efficacy, establishing a strong brand reputation in the market, recognized as one of the most favored pesticide brands by Chinese farmers[44] Industry Overview - The total assets of the pesticide industry in China reached 266.05 billion RMB, with a 5.6% year-on-year increase[47] - The total profit of the pesticide industry was 19.78 billion RMB, a slight decrease of 0.2% year-on-year[47] - The production of chemical pesticide raw materials increased by 1.4% to 2,254,000 tons, ending a two-year decline[48] - The pesticide export trade volume decreased by 5.0% to 5.62 billion USD, with a trade surplus decline of 9.8%[49] - The pesticide industry in China has over 2,000 production enterprises, with a low concentration level, indicating significant room for improvement[123] - The "13th Five-Year Plan" aims to reduce the number of pesticide raw material enterprises by 30% by 2020, with top 20 enterprises expected to account for 70% of total sales[124] - Recent changes in the pesticide industry include stricter regulations and a shift towards value-added services and differentiated competition[127] - The promotion of new environmentally friendly pesticides will significantly optimize the product structure of the pesticide industry, meeting agricultural production needs while reducing environmental impact[128] - The goal of the "13th Five-Year Plan" for the pesticide industry is to cultivate 2-3 large enterprises with sales exceeding 10 billion yuan by 2020, and for the top 20 pesticide companies to account for over 70% of the total national pesticide sales[130] - The pesticide industry is undergoing accelerated consolidation, aiming for a more concentrated and large-scale development, with a focus on enhancing international competitiveness[131] Research and Development - The company emphasizes the importance of R&D and market channel competition in the pesticide industry, focusing on high-efficiency and low-toxicity products[126] - The company plans to enhance its R&D capabilities and establish a sustainable innovation system to increase the technological content and added value of pesticide products[129] - The company aims to build a comprehensive agricultural service platform, focusing on seven strategic areas including talent development, technological innovation, and international market expansion[133] - The company intends to increase investment in strategic raw material products and expand its integrated strategy advantages in raw material formulations[134] - The company prioritizes technological empowerment, ensuring leading R&D capabilities and developing a top-tier research team to maintain competitive advantages[138] Corporate Governance - The actual controller and shareholders committed to not transferring or entrusting the management of shares for 36 months post-IPO, with a further commitment not to reduce holdings for two years after the lock-up period[164] - If the stock price falls below the issue price for 20 consecutive trading days within six months post-IPO, the lock-up period will automatically extend by six months[166] - The company and its actual controller committed to repurchase shares and compensate investors in case of false statements or omissions affecting issuance conditions[166] - The company has established a plan to protect the interests of minority shareholders and investors[175] - The company has made commitments regarding shareholding reductions by major shareholders to comply with regulations[174] Social Responsibility - The company has actively engaged in social responsibility initiatives, contributing to local economic development[198] - The company has received recognition as an excellent unit in investor education and protection activities in Qingdao[200] - The company emphasizes the importance of corporate culture and has organized multiple outdoor activities and training sessions for employees[199] - The company has maintained a focus on employee health and development through various initiatives[199] - The company has invested in safety and environmental protection, adhering to national regulations and standards[200] - The company has not experienced any major violations of environmental laws or significant pollution incidents during the reporting period[200]

Financial Performance - Operating income for the first nine months was CNY 1,967,082,956.50, representing a year-on-year increase of 19.10%[6] - Net profit attributable to shareholders decreased by 12.76% to CNY 276,680,322.84 compared to the same period last year[6] - Basic earnings per share were CNY 1.63, down 13.76% from CNY 1.89 in the same period last year[6] - The company's operating revenue for Q3 2019 was RMB 1,967,082,956.50, representing a 19.10% increase compared to RMB 1,651,668,037.72 in the same period last year[12] - Total operating revenue for Q3 2019 reached ¥536,725,901.59, a 33.4% increase from ¥402,282,875.27 in Q3 2018[24] - Net profit for Q3 2019 was ¥75,978,999.41, slightly down from ¥76,653,383.13 in Q3 2018, representing a decrease of 0.9%[25] - The total profit for Q3 2019 was ¥95,227,630.11, compared to ¥93,672,949.34 in Q3 2018, reflecting a growth of 1.7%[25] - The company experienced a net profit of ¥276,680,322.84 for the first three quarters of 2019, down from ¥317,079,632.05 in the same period of 2018, representing a decline of 12.7%[25] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,172,091,311.21, a decrease of 1.78% compared to the end of the previous year[6] - Total liabilities reached CNY 1,177,873,565.53, compared to CNY 869,121,211.96 in the same period last year, indicating a significant increase of about 35.5%[22] - Owner's equity totaled CNY 1,035,594,256.20, slightly down from CNY 1,045,638,002.21 year-over-year, showing a decrease of approximately 1.0%[23] - The company reported a total liability to equity ratio of approximately 1.14, indicating a higher leverage compared to the previous year[23] - Total assets as of September 30, 2019, amounted to CNY 2,213,467,821.73, an increase from CNY 1,914,759,214.17 in the previous year, reflecting a growth of approximately 15.6%[21] - Current liabilities totaled CNY 1,253,121,078.91, with short-term borrowings at CNY 243,000,000.00 and accounts payable at CNY 365,529,665.90[37] Cash Flow - Net cash flow from operating activities was CNY 181,700,982.79, a significant increase of 600.32% compared to a negative cash flow in the same period last year[6] - The net cash flow from operating activities for the first three quarters of 2019 was RMB 181,700,982.79, a significant recovery from a net outflow of RMB -82,688,437.42 in the same period of the previous year[29] - The company reported cash inflows from investment activities totaling RMB 2,499,400.00, a decrease from RMB 991,776,729.50 in the previous year[30] - The net cash flow from financing activities was RMB -220,412,777.46 in the first three quarters of 2019, a decline from a net inflow of RMB 258,801,906.99 in the previous year[30] - The company’s cash and cash equivalents at the end of the third quarter of 2019 stood at RMB 463,304,086.39, compared to RMB 400,275,047.97 at the end of the same period in 2018[30] Shareholder Information - The total number of shareholders at the end of the reporting period was 12,590[10] - The top ten shareholders held a combined 70.44% of the company's shares, with the largest shareholder owning 38.27%[10] Research and Development - Research and development expenses increased by 41.98% to RMB 72,219,980.25, reflecting a stronger commitment to R&D[12] - Research and development expenses for Q3 2019 were ¥17,577,527.21, an increase of 59.8% compared to ¥11,030,029.25 in Q3 2018[24] - R&D expenses in the first three quarters of 2019 totaled ¥25.47 million, up from ¥21.81 million in the same period of 2018[27] Inventory and Receivables - Accounts receivable increased by 28.24% to RMB 570,369,239.01 from RMB 430,518,225.71, attributed to seasonal sales patterns[12] - Accounts receivable increased significantly to CNY 428,002,113.54 from CNY 238,321,922.84, reflecting a growth of about 79.5%[21] - Inventory decreased to CNY 237,757,970.90 from CNY 351,606,123.04, indicating a decline of approximately 32.4%[21] Financial Adjustments and Standards - The company reported a significant adjustment of CNY -2,820,000.00 in available-for-sale financial assets as of January 1, 2019[39] - The company implemented new financial instrument standards effective January 1, 2019, which may impact future financial reporting[38]

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the first half of 2019, representing a year-on-year increase of 15%[20]. - The net profit attributable to shareholders was RMB 300 million, up 20% compared to the same period last year[20]. - The company's operating revenue for the first half of the year reached ¥1,430,357,054.91, an increase of 14.48% compared to ¥1,249,385,162.45 in the same period last year[21]. - Net profit attributable to shareholders decreased by 16.54% to ¥200,701,323.43 from ¥240,487,242.20 year-on-year[21]. - Basic earnings per share fell by 17.48% to ¥1.18, down from ¥1.43 in the previous year[23]. - The weighted average return on equity decreased by 4.11 percentage points to 9.75% from 13.86% year-on-year[23]. - The net cash flow from operating activities improved significantly, reaching ¥73,268,569.42 compared to a negative cash flow of ¥36,317,195.94 in the same period last year[22]. - The company reported a total of ¥4,553,997.08 in non-recurring gains and losses, primarily from government subsidies and other non-operating income[25]. - The net profit attributable to the parent company was CNY 201 million, a decrease of 16.54% compared to the previous year, primarily due to the low prices of active ingredients like imidacloprid and acetamiprid[42]. - The company reported a total comprehensive income of 240,487,242.20 RMB, with a decrease of 60,993,240.28 RMB compared to the previous period[152]. Research and Development - Research and development expenses increased by 25% to RMB 150 million, focusing on innovative agricultural solutions[20]. - The company has increased its R&D investment, with R&D expenses rising by 57.93% to CNY 54.64 million[48]. - Research and development expenses for the first half of 2019 were CNY 54,642,453.04, compared to CNY 34,598,887.90 in the same period of 2018, reflecting a growth of 58%[137]. - The company plans to enhance R&D investment to improve production stability and reduce costs amid market fluctuations[56]. Market Expansion - The company plans to launch three new pesticide products in Q3 2019, targeting a market share increase of 5% in the next year[20]. - The company is expanding its market presence in Southeast Asia, with a projected investment of RMB 200 million over the next two years[20]. - The company is actively expanding its overseas market presence, having obtained support registrations for over 800 products in 50 countries, including Australia and New Zealand[40]. - The company aims to expand its market presence by strengthening domestic partnerships and exploring international markets[56]. - The company plans to expand into emerging international markets to diversify its revenue streams and reduce reliance on domestic sales[63]. Environmental Compliance - The company is classified as a key pollutant discharge unit, with effective environmental management systems certified according to GB/T24001-2016/ISO14001:2015 standards[89]. - The company has achieved compliance in waste gas and wastewater emissions during the reporting period, with specific pollutant concentrations meeting regulatory standards[91]. - The company has established effective comprehensive treatment measures for waste management, ensuring compliance with environmental regulations[92]. - No significant environmental violations or pollution incidents occurred during the reporting period, and no major administrative penalties were imposed[99]. - The company has established an emergency response plan for environmental incidents, which was reviewed and publicly disclosed[97]. Shareholder Commitments - The actual controller and shareholders have committed to not transferring shares for six months post-IPO, with a two-year lock-up period thereafter[68]. - The company has committed to not transferring or entrusting its shares for 36 months post-IPO, with a maximum of 25% of shares allowed for transfer in the subsequent two years[70]. - The company has established a commitment to compensate investors for losses caused by non-compliance with the above commitments, except for uncontrollable circumstances[74]. - The major shareholders have agreed to disclose any reduction plans 15 trading days in advance if they plan to reduce their holdings through the stock exchange[75]. Financial Position - The company's total assets decreased by 2.55% to ¥3,147,359,618.81 from ¥3,229,574,444.83 at the end of the previous year[22]. - Total current assets decreased to ¥1,982,304,513.99 as of June 30, 2019, down from ¥2,108,160,653.98 at the end of 2018, representing a decline of approximately 6.0%[128]. - Total liabilities decreased to ¥975,554,416.93 from ¥1,273,009,895.25, a decline of about 23.4%[130]. - Total equity increased to ¥2,171,805,201.88, up from ¥1,956,564,549.58, showing a growth of approximately 11.0%[130]. - The total owner's equity attributable to the parent company was 1,045,638,002.21 RMB at the end of the reporting period[155]. Corporate Governance - The company appointed Zhongxinghua Accounting Firm as the auditor for the 2019 fiscal year, approved at the annual general meeting on May 29, 2019[79]. - The company reported no significant litigation or arbitration matters during the reporting period[79]. - The company has not reported any significant changes in shareholder commitments or compliance issues during the reporting period[68]. - The company has not experienced any significant changes in accounting policies or estimates during the reporting period[103]. Risk Management - The company has no significant risks impacting its operations during the reporting period, ensuring stable growth[20]. - The company is closely monitoring changes in agricultural and chemical industry regulations, which may directly impact raw material procurement, production, and sales activities[62]. - The company is facing potential risks from trade protectionism and economic downturns in target export markets, which could affect overall performance[63]. - The company is adopting foreign exchange hedging strategies to mitigate risks associated with RMB/USD exchange rate fluctuations, as export business is expected to increase[63].

Financial Performance - In 2018, the company's operating revenue reached ¥2,191,465,177.73, representing a growth of 37.88% compared to ¥1,589,421,937.70 in 2017[20]. - The net profit attributable to shareholders was ¥367,401,372.13, an increase of 28.45% from ¥286,035,336.33 in the previous year[20]. - The basic earnings per share rose to ¥2.19, marking a 26.59% increase from ¥1.73 in 2017[20]. - The net cash flow from operating activities surged by 509.23%, reaching ¥244,307,282.99, compared to a negative cash flow of ¥59,699,333.59 in 2017[20]. - Total assets increased by 40.71% to ¥3,229,574,444.83, up from ¥2,295,220,889.36 in 2017[20]. - Operating profit reached RMB 421.25 million, up 28.31% from RMB 328.32 million year-on-year[49]. - The company achieved a consolidated revenue of 2.191 billion yuan in 2018, representing a year-on-year growth of 37.88%[41]. - The company reported a total cost of CNY 1,416,767,703.87, with the pesticide segment accounting for 89.64% of total costs[57]. Dividend Policy - The company plans to distribute a cash dividend of 3 RMB per 10 shares to all shareholders, subject to approval at the shareholders' meeting[5]. - In 2018, the company continued with a cash dividend of 3 RMB per 10 shares, with a total cash dividend amounting to 50,819,958 RMB, representing 13.83% of the net profit attributable to ordinary shareholders[137]. - The cash dividend distribution plan for 2018 was based on a total share capital of 169,399,860 shares, with the final cash dividend amount subject to actual distribution[137]. - The company has a cash dividend policy that mandates a minimum of 10% of distributable profits to be allocated for cash dividends when conditions are met[133]. - The company has committed to maintaining shareholder value through consistent dividend payments while ensuring long-term operational stability[139]. Risk Management - The company reported no significant risks that could materially affect its operations during the reporting period[7]. - The company emphasizes the importance of risk awareness regarding forward-looking statements in its report[6]. - The company faces risks related to safety production and environmental protection due to the nature of its pesticide production, which involves flammable, explosive, and toxic substances[126]. - Fluctuations in raw material prices and production instability pose risks to the company's pesticide raw material products, influenced by market demand and environmental pressures[128]. - The company is exposed to risks from upstream raw material supply and price volatility, which can affect production costs and gross margins[129]. Research and Development - The company has been recognized as a "National Key High-tech Enterprise" and has established a strong R&D center since 2003[37]. - The company’s R&D expenses increased by 83.98% to RMB 90.68 million, indicating a strong focus on innovation[51]. - The company is focusing on expanding its business layout across raw materials, formulations, and exports to enhance its competitive edge[82]. - The company has developed new technologies for safe herbicides and high-efficiency pesticides, contributing to improved product performance[85]. - The company plans to enhance its product development capabilities, focusing on new compound research and expanding the production capacity of existing active ingredients[120]. Environmental Compliance - The company has a strong focus on safety and environmental protection, adhering to national regulations without any major violations during the reporting period[176]. - The company has established an environmental management system certified to meet the GB/T24001-2004idtISO14001:2004 standard[181]. - The company has implemented effective comprehensive treatment measures for waste water, waste gas, waste residue, and noise[181]. - The company has developed an emergency response plan for environmental incidents and conducted drills as required[188]. - The company has not experienced any major violations of environmental laws or regulations during the reporting period[190]. Market Position and Strategy - The company continues to focus on the research, production, and sales of pesticide formulations, intermediates, and raw materials, with no significant changes in its main business operations[27]. - The pesticide segment accounted for 91.05% of total revenue, with a revenue of CNY 1,995,448,576.78, but saw a decrease in gross margin by 3.39 percentage points[54]. - The company ranks 27th in the overall pesticide industry and 5th in the pesticide formulation segment according to the 2018 China Pesticide Industry Sales Top 100 List[79]. - The company is expanding its business model to include government procurement and cooperative purchasing with farmers' cooperatives[95]. - The company aims to enter the top ten in the pesticide industry and achieve a revenue of over 10 billion yuan within five years[119]. Corporate Governance - The audit report issued by Zhongxinghua Certified Public Accountants was a standard unqualified opinion[4]. - The company has established a commitment to transparency and accountability in its financial disclosures and investor communications[143]. - The company has appointed Zhongxinghua Accounting Firm as the auditor for the 2018 fiscal year, with an audit fee of RMB 700,000[153]. - The company has implemented a restricted stock incentive plan, which was approved in a board meeting on January 22, 2018[154]. - The company has not reported any issues regarding the integrity of its controlling shareholders or actual controllers[154].

2019 年第一季度报告 公司代码：603639 公司简称：海利尔 海利尔药业集团股份有限公司 2019 年第一季度报告 1 / 19 | 一、 | 重要提示 3 | | --- | --- | | 二、 | 公司基本情况 3 | | 三、 | 重要事项 5 | | 四、 | 附录 8 | 2019 年第一季度报告 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 未出席董事情况 | 未出席董事姓名 | 未出席董事职务 | 未出席原因的说明 | 被委托人姓名 | | --- | --- | --- | --- | | 姜省路 | 独立董事 | 工作原因 | 孙建强 | | 杨波涛 | 董事 | 工作原因 | 徐洪涛 | 1.3 公司负责人葛尧伦、主管会计工作负责人方洁及会计机构负责人（会计主管人员）方洁保证 季度报告中财务报表的真实、准确、完整。 1.4 本公司第一季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 | | | | 单位：元 币种：人民币 | | | ...

Financial Performance - Operating revenue rose by 12.91% to CNY 601,662,147.59 year-on-year[6] - Net profit attributable to shareholders decreased by 24.32% to CNY 68,421,552.07 compared to the same period last year[6] - Basic earnings per share decreased by 24.07% to CNY 0.41[6] - Net profit decreased by 24.31% to CNY 68,421,552.07 from CNY 90,397,483.99, attributed to a decline in gross margin and rising expenses[11] - Net profit for Q1 2019 was CNY 68,421,552.07, a decrease of 24.3% from CNY 90,397,483.99 in Q1 2018[25] - The company reported a total profit of ¥3,661,200.17 for Q1 2019, down 89.6% from ¥35,118,882.24 in Q1 2018[28] Assets and Liabilities - Total assets increased by 7.95% to CNY 3,486,450,905.37 compared to the end of the previous year[6] - Total assets as of March 31, 2019, amounted to CNY 3,486,450,905.37, compared to CNY 3,229,574,444.83 at the end of 2018[18] - Total liabilities increased to CNY 1,454,258,213.57 from CNY 1,273,009,895.25, indicating a rise in financial obligations[18] - Total liabilities for Q1 2019 were CNY 945,615,610.21, up from CNY 869,121,211.96 in Q1 2018, indicating an increase of 8.8%[22] Cash Flow - Cash flow from operating activities showed a slight improvement, with a net cash outflow of CNY 61,904,237.26, a decrease of 1.00% year-on-year[6] - The cash flow from operating activities showed a net outflow of ¥61,904,237.26, slightly improved from a net outflow of ¥62,531,724.56 in Q1 2018[31] - Cash inflow from operating activities for Q1 2019 was $197.21 million, up from $131.76 million in Q1 2018, representing a 49.6% increase[34] - Net cash flow from operating activities for Q1 2019 was -$135.56 million, slightly worse than -$134.58 million in Q1 2018[34] Shareholder Information - The number of shareholders reached 12,586 at the end of the reporting period[8] - The top shareholder, Zhang Aiying, holds 38.33% of the shares, totaling 64,925,000 shares[8] Expenses - Research and development expenses increased by 86.06% to CNY 20,385,158.61, reflecting a stronger commitment to innovation[11] - The company reported a significant increase in sales expenses, which rose by 43.80% to CNY 42,423,957.10 due to higher personnel and travel costs[11] - Management expenses surged by 58.44% to CNY 30,557,370.59, driven by stock incentives and depreciation[11] - Research and development expenses rose to CNY 20,385,158.61 in Q1 2019 from CNY 10,956,120.27 in Q1 2018, reflecting an increase of 86.5%[24] Accounts Receivable and Inventory - Accounts receivable increased by 28.24% to CNY 555,165,427.30 due to seasonal sales[10] - Accounts receivable increased to CNY 280,395,248.23 in Q1 2019 from CNY 238,321,922.84 in Q1 2018, representing a growth of 17.6%[21] - Inventory decreased to CNY 291,329,734.57 in Q1 2019 from CNY 351,606,123.04 in Q1 2018, a decline of 17.1%[21] Cash and Cash Equivalents - The company's cash and cash equivalents stood at CNY 800,590,353.49, up from CNY 721,888,335.57 at the end of 2018[16] - Cash and cash equivalents at the end of Q1 2019 totaled ¥756,098,924.00, an increase from ¥460,754,713.06 at the end of Q1 2018[32] - The ending cash and cash equivalents balance for Q1 2019 was $340.38 million, up from $154.95 million in Q1 2018, reflecting a 119.9% increase[35] Financing Activities - Short-term borrowings rose to CNY 403,000,000.00, up 65.84% from CNY 243,000,000.00, primarily due to temporary liquidity needs[11] - The company received $360 million in borrowings during Q1 2019, compared to $70 million in Q1 2018, indicating a 414.3% increase in financing[35] - The financing activities generated a net cash inflow of ¥146,106,903.95 in Q1 2019, compared to ¥69,965,800.72 in Q1 2018[32] - Net cash flow from financing activities for Q1 2019 was $218.50 million, improving from -$10.99 million in Q1 2018[35]

Financial Performance - In 2018, the company's operating revenue reached ¥2,191,465,177.73, representing a growth of 37.88% compared to ¥1,589,421,937.70 in 2017[20]. - The net profit attributable to shareholders was ¥367,401,372.13, an increase of 28.45% from ¥286,035,336.33 in the previous year[20]. - The basic earnings per share rose to ¥2.19, marking a 26.59% increase from ¥1.73 in 2017[20]. - The net cash flow from operating activities surged by 509.23%, reaching ¥244,307,282.99, compared to a negative cash flow of ¥59,699,333.59 in 2017[20]. - Total assets increased by 40.71% to ¥3,229,574,444.83, up from ¥2,295,220,889.36 in 2017[20]. - The company achieved a consolidated revenue of 2.191 billion yuan in 2018, representing a year-on-year growth of 37.88%[41]. - Operating profit reached RMB 453,623,500, a 38.17% increase compared to RMB 328,319,200 from the previous year[49]. - Net profit attributable to shareholders was RMB 393,839,600, reflecting a 37.69% growth from RMB 286,035,300 in the prior year[49]. Dividend Policy - The company plans to distribute a cash dividend of 3 RMB per 10 shares to all shareholders, subject to approval at the shareholders' meeting[5]. - In 2016, the company distributed a cash dividend of 2 RMB per 10 shares, totaling 24,000,000 RMB, which represented 16.41% of the net profit attributable to ordinary shareholders[137]. - In 2017, the cash dividend increased to 3 RMB per 10 shares, totaling 36,000,000 RMB, accounting for 12.59% of the net profit attributable to ordinary shareholders[137]. - In 2018, the company maintained a cash dividend of 3 RMB per 10 shares, with a total distribution of 50,819,958 RMB, representing 13.83% of the net profit attributable to ordinary shareholders[137]. - The company plans to conduct cash dividends annually after the shareholders' meeting, based on profitability and funding needs[134]. Risk Management - The company reported no significant risks that could materially affect its operations during the reporting period[7]. - The company emphasizes the importance of risk awareness regarding forward-looking statements in the report[6]. - The company faces risks related to safety production and environmental protection due to the nature of its pesticide production, which involves flammable, explosive, and toxic substances[126]. - Fluctuations in raw material prices and production instability pose risks to the company's pesticide raw material products, influenced by market demand and environmental pressures[128]. - The company is exposed to risks from upstream raw material supply and price volatility, which can significantly impact production costs and gross margins[129]. - The company will closely monitor changes in industry regulations and policies to ensure compliance and mitigate operational risks[131]. Research and Development - The company has been recognized as a "National Key High-tech Enterprise" and has established a strong R&D center since 2003[37]. - The company’s R&D expenses increased by 83.98% to RMB 90,684,326.68, indicating a strong focus on innovation[51]. - The company has developed new generations of neonicotinoid insecticides, further enhancing its product offerings and market position[36]. - The company aims to improve product quality and operational efficiency through a focus on quality management and innovation[123]. - The company plans to strengthen its international market expansion by enhancing product registration abroad and increasing export capabilities for formulations and active ingredients[120]. Environmental Compliance - The company has achieved compliance with emission standards for both waste gas and waste water during the reporting period[179]. - The total emissions of particulate matter, SO2, NOx, and VOCs are 5.9762 tons, 6.9708 tons, 12.5315 tons, and 38.87 tons per year respectively[184]. - The company has established an environmental management system certified to meet the ISO 14001:2004 standard[181]. - The company has implemented effective pollution control measures, including a wastewater treatment plant and various air pollution control devices[185]. - No significant violations of environmental laws or pollution incidents occurred during the reporting period[190]. Corporate Governance - The financial report has been audited by Zhongxinghua Certified Public Accountants, providing a standard unqualified opinion[4]. - The company has established a commitment to transparency and accountability regarding its IPO process and shareholder management[143]. - The company has made a long-term commitment to ensure that the IPO prospectus does not contain false records or misleading statements[143]. - The company has appointed Zhongxinghua Accounting Firm as the auditor for the 2018 fiscal year, with an audit fee of RMB 700,000[153]. - The company has implemented a restricted stock incentive plan, which was approved in a board meeting on January 22, 2018[154].

| 目录 | | --- | | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 6 | | 四、 | 附录 | 9 | 2018 年第三季度报告 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 2018 年第三季度报告 公司代码：603639 公司简称：海利尔 海利尔药业集团股份有限公司 2018 年第三季度报告 1 / 21 1.3 公司负责人葛家成、主管会计工作负责人方洁及会计机构负责人（会计主管人员）方洁保证 季度报告中财务报表的真实、准确、完整。 1.4 本公司第三季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 3 / 21 单位：元 币种：人民币 本报告期末 上年度末 本报告期末比上年度 末增减(%) 总资产 2,922,452,211.51 2,295,220,889.36 27.33 归属于上市公司股东的 净资产 1, ...